chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Vaccine used past its 30 day expiry date; Patient received vaccine past its 30 day expiry date; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received vaccine past its 30 day expiry date) and PRODUCT STORAGE ERROR (Vaccine used past its 30 day expiry date) in a 47-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066H21A) for COVID-19 vaccination. No Medical History information was reported.    On 19-Feb-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 19-Feb-2022 at 12:57 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received vaccine past its 30 day expiry date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine used past its 30 day expiry date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received vaccine past its 30 day expiry date) and PRODUCT STORAGE ERROR (Vaccine used past its 30 day expiry date) outcome was unknown.  For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Dose description included: Booster.  No Concomitant medications were reported Vaccine went into 2 to 8 degree Celsius thaw state on about 24 Dec 2021. The vaccine was administered up until its manufacturing expiry date of 04 Apr 2022. No Treatments were reported. This case was linked to MOD-2022-542869 (Patient Link).
Initially I had soreness,swelling and redness in my left arm. after about four days soreness disappears  but the swelling still there and circumferential red blotch  with itching persist
Initial information received on 15-Oct-2018 regarding an unsolicited valid non-serious case received from a consumer. This case involves Elderly female patient who experienced vomiting, pain in right arm (reported as right arm could not lift up and in pain), throat tightness (reported as it felt like her throat was closing up) and diagnosed with an allergic reaction, while she received vaccines PREVNAR and FLUZONE HIGH DOSE. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medication was not reported. On an unknown date, the patient received a dose of suspect PREVNAR not produced by Sanofi Pasteur lot number not reported. On an unknown date, the patient received a dose of suspect INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE lot number not reported via unknown route in the right arm. On an unknown date, the patient developed a non-serious vomiting following the administration of INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE and following the administration of PREVNAR. On an unknown date ,the patient developed a non-serious right arm could not lift up and in pain (pain in extremity) following the administration of INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE and following the administration of PREVNAR. On an unknown date, the patient developed a non-serious it felt like her throat was closing up (throat tightness) following the administration of INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE and following the administration of PREVNAR. On an unknown date, the patient developed a non-serious diagnosed with an allergic reaction (hypersensitivity) following the administration of INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE and following the administration of PREVNAR. (Other relevant tests included No lab data.) Final diagnosis was diagnosed with an allergic reaction, it felt like her throat was closing up, right arm could not lift up and in pain and vomiting. It was not reported if the patient received a corrective treatment. The patient outcome is reported as Unknown for vomiting, as Unknown for right arm could not lift up and in pain, as Unknown for it felt like her throat was closing up and as Unknown for diagnosed with an allergic reaction. Documents held by sender: none.
32 yr male without Preexisting history, observed with stiffening, tonic/clonic response 2 minutes within vaccination; fell out of chair, hit head. Attendee self awoke, alert, oriented x 2 within one minute. EMS called, declined ER trip, monitored and d/c from EMS after speaking with ER MD(phone). Walking independently.
Vaccines went into 2-8 C thaw state on or about 24-Dec-2021 and administered on 20-Feb-2022; Received vaccine past its 30-days Exp date; This spontaneous case was reported by an emergency medical technician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received vaccine past its 30-days Exp date) and PRODUCT STORAGE ERROR (Vaccines went into 2-8 C thaw state on or about 24-Dec-2021 and administered on 20-Feb-2022) in a 25-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066h21A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Feb-2022 at 1:28 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 20-Feb-2022 at 1:28 PM,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (Received vaccine past its 30-days Exp date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccines went into 2-8 C thaw state on or about 24-Dec-2021 and administered on 20-Feb-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Received vaccine past its 30-days Exp date) and PRODUCT STORAGE ERROR (Vaccines went into 2-8 C thaw state on or about 24-Dec-2021 and administered on 20-Feb-2022) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.    No concomitant medications information was reported.  Patient received the booster dose.  It was reported that vaccines went into 2-8 C thaw state on or above 24-Dec-2021 and were administered up until the MFG expiry date of 04-Apr-2022.  No treatment medications were provided.   This case was linked to MOD-2022-542869 (Patient Link).
2mins after receiving vaccine throat tightening, 3mins later swollen throat, narrow airways, coughing stridor, than wheezing. Immediately given, 2liters oxygen, IM injections; decadrone, soluMedrol, Epipen, than oral Benadryl, Monitored O2, pulse, BP. Than transported to Hospital for monitoring/observation.
No adverse event; Vaccine administered after beyond use date 07-Jul-2022; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine administered after beyond use date 07-Jul-2022) and NO ADVERSE EVENT (No adverse event) in a 23-month-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. AS1414B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 09-Jul-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine administered after beyond use date 07-Jul-2022). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine administered after beyond use date 07-Jul-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Vaccine administered after beyond use date 07-Jul-2022).    No concomitant medication was reported.  The vaccine beyond use date was 07Jul 2022.  No treatment information was provided.
Initial information received on 05-Dec-2018 regarding an unsolicited valid non-serious case received from a consumer. This case involves a 13 years old female patient who became ill with sore throat and fever, while she received vaccine Influenza Vaccine. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 02-Dec-2018, the patient received a dose of suspect Influenza Vaccine produced by unknown manufacturer lot number, Exp. Date, route and administration site not reported. On an unknown date, the patient became ill (malaise) with sore throat (oropharyngeal pain) and fever (pyrexia) 1 day following the administration of Influenza Vaccine. It was reported that, the patient felt better next day. Details of lab data not provided. Final diagnosis was became ill with fever and sore throat. It was not reported if the patient received a corrective treatment. On an unknown date, the patient recovered from events. List of documents held by sender- none.
redness 2 inches in diameter.  warm to touch.  no other s/s reported.
20cm X 7cm reddened and hot area on left are. Ice for 15 min every hour X 6. Benadryl 25mg now and 1 every 6 hours while at work. May take 50mg Benadryl at bedtime. On 03/19/2003 reddened area decreased to 5cm X 5cm. Much improved.
Moderna COVID-19 Vaccine EUA  bad rash all over body (hives)  sore throat fatigue  swollen fingers, wrists, eyes, ankles
Son had seizure that lasted about 3-4 minutes and turned blue, so teachers started CPR. Was taken in ambulance to hospital where it was discovered he had a fever of 102.5.
Cellultis. Tx: CEPHALEXIN 250 mg/5 ml, 5 ml tid x 10 days
patient diagnosed with Erythema Multiforme Minor. triamcinolone ordered. encouraged to continue Benadryl, Tylenol, and motrin PRN.  Rash flared and waned since august after first JEV, but fever and worsening rash after 2nd dose of the JEV.
Electricity in my legs; This is a spontaneous report from a contactable consumer, the patient. A 75-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6208) via an unspecified route of administration in the left arm on 10Mar2021 at 14:30 (at the age of 75-years-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included amlodipine (MANUFACTURER UNKNOWN), losartan (MANUFACTURER UNKNOWN), vitamin d nos (VIT D) and zinc (MANUFACTURER UNKNOWN); all for unknown indications from unknown dates and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14Mar2021 at 09:00, the patient experienced electricity in legs. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event electricity in legs was unknown at the time of this report.  No follow-up attempts are needed. No further information is expected.
fever; body aches; mild vertigo; The first dose was received on 02Dec2020 and the second dose was received on 16Jan2021; This is a spontaneous report from a contactable Other Health Professional reporting for herself. A 52-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number unknown), via an unspecified route of administration (left arm) from 16Jan2021 17:30 (05:30 PM) at SINGLE DOSE for covid-19 immunisation. Medical history included known allergies: Keflex and sulfa from unspecified date. Patient is not pregnant. No other vaccine was given in four weeks. Patient did not have COVID prior vaccination. Patient was not tested for COVID post vaccination. Concomitant medication included botulinum toxin type a (BOTOX), and ibuprofen (MOTRIN) from an unspecified date for an unspecified indication (medications in two weeks). The patient previously took the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number unknown) on 02Dec2020 07:45 AM, Left arm. The first dose was received on 02Dec2020 and the second dose was received on 16Jan2021. The patient experienced fever, body aches, mild vertigo on 17Jan2021 12:00. Treatment was not given. Outcome of the events was recovered in 2021.  Information about lot/batch number has been requested.
Approximately  1 week after MMR pt. experienced joint "soreness"(wrist, knee,ankle).She also developed swelling in both wrists. Pt. was given and took a Rx. for Naprosyn 500 mg to be taken daily. Swelling has decreased since taking Rx. and is experiencingless pain.
Pt reported on 12/13/22 that he had pain and a small nodule after getting moderna back on 3/01/22.  The pain and nodule lasted a couple of months but has resolved completely.
pt recvd vax on 17jan90;pt inadvertently recvd a 2nd dose of HEP B on 15feb90;at time of report no problems noted;
Sore arm initially - other that that, no problems.  Noticed bruising on the morning of Friday 11/19/21.  Saturday bruising was almost double in size,  Sunday larger still.  Just seemed odd to have no bruising for two days before the bruise appeared and then stared to spread out across my arm
Localized swelling and puritus at injection site Delayed onset by approx. 7 days from initial dose Firmness around injection site consistent with "covid arm"
Extreme and disabling aggravation of my chronic Lyme syndrome symptoms, including intense pain in head, eyes, arms, hands, feet, ribs, teeth, gums, etc. generalized body aches, malaise, extreme fatigue, painful urination, unprecedented outbreak of painful skin eruptions (acne-sized bumps and fine rashes on face, forehead, scalp and back), numerous painful sores on tongue and inside of cheeks, etc. Treatment: ibuprofen, bed rest. Symptoms slowly improving but still present at time of this report (7 weeks after immunization), painful skin eruptions continue.
Information has been received from a male who in December 2007, was vaccinated with ZOSTAVAX (Merck) (lot no., route, injection site not reported).  Shortly after the vaccination, on the same day, the patient experienced upset stomach.  The patient did not seek medical attention.  No further information is available.
Chills first, then fever (101.3), body aches, headaches, fatigue. Lasting about 12 hours.
Within 2 minutes post vaccination i started feeling loss of sense of myself. I could not pinpoint if i felt dizzy or vertiginous. Felt like i was off balance and i was super vernous to walk. Vertiginous episodes come and go with peaks for at least 10 times. The whole episode lasted 4 hours until i felt going back to myself.   I was provided water, 1 L and orange juice, there was epi available. No anaphylactic symptoms, no shortness of breath.   I drank 1,5 L of fluids and then my BP was checked 120/80, HR 80s.  I note that i never felt syncopal,  no diaphoresis, nausea, nor darkened vision and i was fully interactive with the bystanders.  Note, i am a critical care intensivist so i had full grasp of the issue but i could now quite describe the sensation of this acute loss of instability. The best way to describe this was vertigo. Similar episode occured at the first vaccine with COVID, occured after 10 minutes and lasted no more than 30 seconds. I didnt report that then because i thought it was just dehydration.
woke up with headache with evolved to fever chills sore throat runny nose and body ache all over
Left supraclavicular adenopathy.  Mobile 1 cm  soft lymph node palpation and may have 2 smaller lymph nodes behind it.   I honestly don't think this is an adverse reaction, just a vaccine side effect.  However, enlarged lymph nodes in this area of the body do tend to cause some concern for more serious underlying illnesses, so I thought it was worth reporting so that if this is a common side effect, other health care providers can be made aware so that patients can be educated to expect this.  Thanks.
Information has been received from a mother concerning her consumer 15 year old daughter with a history of infectious mononucleosis who on approximately 31-JUL-2007 was vaccinated with a 0.5 ml first dose of Gardasil.  Concomitant vaccination included Tdap. Subsequently the patient developed swollen lymph nodes.  Unspecified laboratory test was performed.  Unspecified medical attention was sought.  At the time of the report the patient was recovering.  Additional information has been requested.
Shortly after vaccination, patient's tongue swelled. EMS on site. Given benadryl and solumedrol. Transported to ED.
Information has been received from a physician concerning a female (age not reported) who, on an unspecified date, was vaccinated with a dose of GARDASIL. Subsequently, on an unspecified date, the patient developed muscle soreness after vaccination. It was unknown which muscles were involved. The patient was seen in the office. A creatine phosphokinase test was done, results not reported. The outcome was unspecified. Additional information has been requested.
sore arm; nausea.; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) and NAUSEA (nausea.) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Irritable bowel syndrome and GERD.    On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Feb-2021, the patient experienced PAIN IN EXTREMITY (sore arm) and NAUSEA (nausea.). At the time of the report, PAIN IN EXTREMITY (sore arm) and NAUSEA (nausea.) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported  No treatment information was provided.
Redness size of baseball on evening of shot following day now is approx. 8inches by 6inches, hot to touch and swelling.
Injection site knot (hardness); Injection site itchy; Injection site red; injection site sore; Injection site hot; Injection site raised; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Injection site hot), VACCINATION SITE REACTION (Injection site raised), VACCINATION SITE INDURATION (Injection site knot (hardness)), VACCINATION SITE PRURITUS (Injection site itchy) and VACCINATION SITE ERYTHEMA (Injection site red) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Type 2 diabetes mellitus.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Mar-2021, the patient experienced VACCINATION SITE WARMTH (Injection site hot), VACCINATION SITE REACTION (Injection site raised), VACCINATION SITE ERYTHEMA (Injection site red) and VACCINATION SITE PAIN (injection site sore). On 18-Mar-2021, the patient experienced VACCINATION SITE INDURATION (Injection site knot (hardness)) and VACCINATION SITE PRURITUS (Injection site itchy). On 11-Mar-2021, VACCINATION SITE WARMTH (Injection site hot) outcome was unknown, VACCINATION SITE REACTION (Injection site raised) and VACCINATION SITE PAIN (injection site sore) had resolved. At the time of the report, VACCINATION SITE INDURATION (Injection site knot (hardness)), VACCINATION SITE PRURITUS (Injection site itchy) and VACCINATION SITE ERYTHEMA (Injection site red) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood glucose fluctuation: unknown (High) Elevated blood sugar.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter. No treatment information was provided.
face is real red; rash on her cheeks and neck; Caller describes the rash as raised like pimples; This is a spontaneous report from a contactable consumer. A 39-years-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection), dose 1 via an unspecified route of administration on an unspecified date as single dose for covid-19 immunisation.  The patient medical history and concomitant medications were not reported. Since she received the vaccine her face was real red and she had a rash on her cheeks and neck. The rash as raised like pimples. The events assessed as non-serious with outcome of event unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
None....wanted to document 3rd dose given 2.5 years after 2nd shot
08:45 am - metallic taste in mouth (2:03p has not gone away) 09:00 am - tongue felt thick and lower lip felt enlarged; this went away after about1 hour 09:00 am - dry mouth feeling  09:00 am - cheeks felt very flush (no fever recorded) 11:45 am - very dizzy (rested for 1 hour and 10 minutes) 14:05 pm - mild headache
This spontaneous report was received from a pharmacist referring to a currently 63 year old male patient. The patient's medical history and concurrent conditions were not reported. None drug reactions or allergies were reported. On 24-OCT-2016, the patient was vaccinated with ZOSTAVAX lot # L035505, expiration date: 16-DEC-2016, dose: 0.65 ml, once, via subcutaneous in the right upper arm. At the same visit, the patient was vaccinated with FLUARIX (lot number, expiration date, concentration, dose, frequency, route of administration and indication were not reported) that was administered the same date at an unspecified site. Concomitant medications were not reported. On 28-OCT-2016, the patient experienced a "widespread rash, which started in his armpits, to his back and groin area, it was also reported that the rash was red and itches", no treatment was given for the adverse event, furthermore, none laboratories or studies were performed, additionally the patient sought medical attention by calling the pharmacist. At the time of the report, the outcome of rash generalised, rash erythematous and rash pruritic was unknown, the causality between the events and therapy with ZOSTAVAX was not reported. Additional information has been requested.
Pt received both Pfizer vaccines. On August 16th, 2021, pt tested positive for COVID-19. Presented to ED with complaint of chest pain, SOB, leg swelling, and difficulty breathing, and was diagnosed with plural effusion.
patient is having the signs of flu like symptoms this is his second dose and the pharmacist failed to tell him what to expect
fever of 102-103 beginning w/in 3hr p/vax;stomach pain mid epigastric (no nausea/vomiting) similar to flu sx, lasted 2 days;fever subsided 1st noc p/motrin;also lethargy & malaise;
FEVER VOMITTING, DROWSINESS FOR 2-3 DAYS, LOCALIZED RASH AND LUMPS (NOT HIVE LOOKING) AROUND BOTH INJECTED VACCINES ADMINISTERED ON LEFT ARM DELTOID FOR 2 - 3 DAYS
Client returned to clinic with Mother 1 day after vaccination L Deltoid site red, inflamed, indurated evaluated by ARNP on staff instructed to use cold compress and oral Benadryl per package directions. if not improved in 24-48 hours rtc. t/c to client's mom next day mom had taken client to Hospital ER dx w/ cellulitis and given rx antibiotic. F/u t/c to 03/12/18 inflammation/induration and redness resolved was completing antibiotic course of tx.